Topics
CNS Tumors | Treatment | Targeted therapy | Nivolumab
Home > Publications > Topics > CNS Tumors > Treatment > Targeted therapy > Nivolumab
André N, Deley MCL,
Léguillette C, Probst A, Willems L, Travers R, Aerts I,
Faure-Conter C, Revond-Riviere G, Min V, Geoerger B, Chastagner P,
Entz-Werlé N, Leblond P.
METRO-PD1:
Phase 1 study of nivolumab in combination with metronomic
chemotherapy in children and adolescents with relapsing/refractory
solid tumors.
Eur
J Cancer. 2024
Jan 6;198:113525. doi:
10.1016/j.ejca.2024.113525. PMID:
38199147. Interventional study. ˍ